Venous Ulcer Clinical Trial
Official title:
A Pilot Study to Investigate the Efficacy of PluroGel in Healing Venous and Mixed Aetiology Leg Ulcers
A randomized controlled study (RCT) to investigate the topical effectiveness of PluroGel in healing venous and mixed aetiology leg ulcers. Patients with venous and mixed aetiology leg ulcers will be identified from hospital outpatient clinics. Willing patients meeting the inclusion and exclusion criteria will be consented and assessed in line with standard care. Participants will be randomized at Week 2 to receive either topical PluroGel or Intrasite gel (an alternative topical hydrogel product) if inclusion criteria is met.
This will be a pilot, randomized, controlled, multi-center trial to determine the effectiveness of PluroGel in the reduction of size of wounds and reduction of slough covering the wound surface compared with Intrasite Gel. The primary objectives will be to evaluate the effectiveness of PluroGel compared with Intrasite Gel in the reduction of size of venous leg ulcers or mixed venous arterial aetiology. Also the reduction in the percentage of slough covering the wound bed in both groups will be compared. The secondary objective will be to evaluate patient comfort, satisfaction and acceptance of the hydrogels along with staff feedback of both hydrogels. Patients with either a venous leg ulcer (VLU) or an mixed venous arterial aetiology (MAU) leg ulcer will be identified by the participant's health care provider and will be treated with PluroGel or Intrasite Gel. A total of 40 subjects will be enrolled to the study, 20 to each arm. These subjects will be recruited from patients receiving treatment for wounds at NHS outpatient clinic. Participants will be approached initially by the NHS care-giver and asked if interested in participating in research. If interested, participants will be asked to sign a permission to contact form for contact details to be given to a member of the research team who would then contact the participant to provide further information. A screening log will be kept of all patients who have been considered but who do not fulfill the criteria for entry. Patients will be randomized to either Plurogel and standard care or Intrasite Gel in conjunction with standard care, on an equal basis. Subjects will be eligible for randomization if during the first two weeks within the study the target wound has not reduced in surface area by 30% or more and there has been a less than 25% reduction in the cover of the wound bed with visible slough. Once the subject has completed 4-weeks of treatment, and the final visit, or the target ulcer has healed, whichever is soonest, then the subject has completed the study and the termination form will be completed. The Investigator will ensure that all CRF forms are completed and accurate. The study end date will be the date of the last subject's last visit. The CI and study sponsor, will comply with any safety reporting obligations for serious adverse device related events to the manufacturer, study sponsor, R&D Department(s) of the University Health Board(s) and the Ethics Committee, as defined in the applicable laws and regulations, and within the required timelines. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05633277 -
Outcomes of Sclerotherapy of the Ulcer Bed Compared to a Combination of Ablation and Injections
|
N/A | |
Recruiting |
NCT02838784 -
Efficacy and Safety of Artacentâ„¢ for Treatment Resistant Lower Extremity Venous and Diabetic Ulcers
|
N/A | |
Completed |
NCT02092870 -
Adipose Derived Regenerative Cellular Therapy of Chronic Wounds
|
Phase 2 | |
Terminated |
NCT00847002 -
Flexitouch Treatment for Venous Ulcers
|
N/A | |
Completed |
NCT01858272 -
Preliminary Testing of New Treatment for Chronic Leg Wounds
|
Phase 1 | |
Not yet recruiting |
NCT05877378 -
Efficacy of PICO Single-use System in Chronic Ulcers
|
N/A | |
Recruiting |
NCT05409976 -
The GORE® VIAFORT Vascular Stent IVC Study
|
N/A | |
Terminated |
NCT01396304 -
Restore Calcium Alginate Dressing, Silver vs Aquacel Ag in the Treatment of Critically Colonized Venous Leg Ulcers
|
Phase 4 | |
Not yet recruiting |
NCT06007703 -
Evaluation of the Efficacy of Multilayer Compression & UrgoStart Plus
|
||
Completed |
NCT04046120 -
Comparison of the Effectiveness of Two Medical Compression Bandage Application Techniques by Measuring Interface Pressures Depending on Whether or Not the Heel is Included in Patients With Open Venous Ulcers
|
N/A | |
Terminated |
NCT04021316 -
Decellularised Dermis Allograft for the Treatment of Chronic Venous Leg Ulceration
|
N/A | |
Completed |
NCT05729334 -
Clinical Investigation EUCLIDES-01 for the Calculation of the Area of Skin Lesions
|
N/A | |
Completed |
NCT03070938 -
PuraPlyâ„¢ Antimicrobial Wound Matrix and Wound Management
|
N/A | |
Terminated |
NCT01853384 -
Safety and Efficacy Trial of HP802-247 in the Treatment of Chronic Venous Leg Ulcers
|
Phase 3 | |
Completed |
NCT00558662 -
Randomized Clinical Trial (RCT) to Compare the Efficacy of Coban 2 Versus SSB in the Treatment of Venous Leg Ulcers
|
N/A | |
Completed |
NCT01750749 -
Cell Therapy for Venous Leg Ulcers Pilot Study
|
Phase 1 | |
Completed |
NCT01327937 -
A Post Marketing Study of Apligraf in Non-healing Wounds of Subjects With Venous Leg Ulcers
|
Phase 4 | |
Completed |
NCT00820196 -
A Trial to Assess the Safety and Activity of Nexagon® for the Treatment of Venous Leg Ulcers (The NOVEL Study)
|
Phase 2 | |
Completed |
NCT00301496 -
Randomized Controlled 8-Week Crossover Evaluation of Compression Bandage Systems for Venous Leg Ulcers
|
N/A | |
Recruiting |
NCT05489588 -
The GORE® VIAFORT Vascular Stent Iliofemoral Study
|
N/A |